Polivaccinum forte Niesvoista shhepionka bakteriina
Ask a doctor about a prescription for Polivaccinum forte Niesvoista shhepionka bakteriina
How to use Polivaccinum forte Niesvoista shhepionka bakteriina
Leaflet attached to the packaging: information for the user
Polyvaccinum forte,suspension for injection
Non-specific bacterial vaccine
Inactivated bacteria: Staphylococcus aureus500 million cells , Staphylococcus epidermidis500 million cells , Streptococcus salivarius100 million cells , Streptococcus pneumoniae100 million cells , Streptococcus pyogenes100 million cells , Escherichia coli200 million cells , Klebsiella
pneumoniae100 million cells , Haemophilus influenzae100 million cells , Corynebacterium
pseudodiphtheriticum200 million cells , Moraxella catarrhalis100 million cells/ 1 ml
Read the leaflet carefully before using the vaccine, as it contains important information for the patient.
- Keep this leaflet, so you can read it again if you need to.
- If you have any doubts, consult a doctor, pharmacist, or nurse.
- This vaccine has been prescribed specifically for this person. Do not pass it on to others. The vaccine may harm another person, even if their symptoms are the same.
- If the patient experiences any side effects, including any side effects not listed in this leaflet, tell the doctor, pharmacist, or nurse. See section 4.
Table of contents of the leaflet
- 1. What is Polyvaccinum forte vaccine and what is it used for
- 2. Important information before using Polyvaccinum forte vaccine
- 3. How to use Polyvaccinum forte vaccine
- 4. Possible side effects
- 5. How to store Polyvaccinum forte vaccine
- 6. Package contents and other information
1. What is Polyvaccinum forte vaccine and what is it used for
Polyvaccinum forte is a bacterial vaccine that stimulates the immune system because it contains killed bacteria that most often cause various types of infections or are the cause of complications of inflammatory conditions of non-bacterial origin. The vaccine is used prophylactically in recurrent respiratory infections in children from 2 to 14 years and adults.
2. Important information before using Polyvaccinum forte vaccine
When not to use Polyvaccinum forte vaccine:
- if the patient is allergic to the active substances or any of the other ingredients of this medicine (listed in section 6). Allergy symptoms may include: itching rash, shortness of breath, facial swelling and tongue,
- if the patient has:
- infectious disease,
- acute inflammatory condition,
- kidney or liver disease,
- circulatory failure,
- systemic disease (a disease that affects several types of tissues and organs or the entire body),
- if the patient is using immunosuppressive preparations (drugs that suppress the body's immune response),
- if the patient is pregnant or breastfeeding,
- in children under 2 years of age.
Warnings and precautions
Vaccination should be preceded by a medical examination and a medical history of the patient's general health and previously performed and recorded vaccinations. This procedure allows for predicting the risk of side effects and changing the dosage regimen. Be particularly careful if, after the previous dose of Polyvaccinum forte vaccine, the side effects described in section 4 or any other disturbing reactions occurred. The vaccine can be used in the course of an infection if vaccination treatment was started before the development of the infection. It is not recommended to use Polyvaccinum forte vaccine to prevent pneumonia, as there are no clinical trial data confirming such an effect. For safety reasons, after vaccination, stay under medical observation for 30 minutes.
Polyvaccinum forte vaccine and other medicines
In patients undergoing immunosuppressive therapy (inhibiting the activity of the immune system), the response to the vaccine may be reduced. In such a case, the doctor may decide to postpone vaccinations until the end of therapy. The vaccine can be used during antibiotic therapy if the doctor considers the administration of an antibiotic necessary. Tell the doctor about all medicines the patient is currently taking or has recently taken, as well as about medicines the patient plans to take.
Pregnancy and breastfeeding
Do not use.
Driving and operating machinery
No studies have been conducted on the effect of the vaccine on the ability to drive and operate machinery.
3. How to use Polyvaccinum forte vaccine
Polyvaccinum forte vaccine will be administered by a doctor or nurse as an intramuscular or subcutaneous injection. The vaccine must never be administered intravenously. The vaccine is administered according to the dosage regimen along with Polyvaccinum submite and Polyvaccinum mite. The product does not replace anti-inflammatory treatment.
Dosage
Dosage regimen
| Injections administered at intervals of 3-5 days | Adults | Children from 2 to 14 years | ||
| Vaccine | Dose | Vaccine | Dose | |
| Injection 1, 2, and 3 | Polyvaccinum submite | 1.0 ml | Polyvaccinum submite | 0.5 ml |
| Injection 4 and 5 | Polyvaccinum mite | 0.5 ml | Polyvaccinum submite | 1.0 ml |
| Injection 6, 7, and 8 | Polyvaccinum mite | 1.0 ml | Polyvaccinum mite | 0.3 ml |
| Injection 9 and 10 | Polyvaccinum forte | 0.3 ml | Polyvaccinum mite | 0.5 ml |
| Injection 11 and 12 | Polyvaccinum forte | 0.5 ml | Polyvaccinum forte | 0.2 ml |
| Injection 13 and 14 | Polyvaccinum forte | 1.0 ml | Polyvaccinum forte | 0.5 ml |
Dose 14 can be repeated at intervals of 2-4 weeks for a period of 2-3 months. The full vaccination cycle shown in the table should be repeated 2 times a year, in the spring and autumn, for at least 2 years. Changing the dosage in the event of prolonged or severe side effects is described in section 4.
Using a higher dose of Polyvaccinum forte vaccine than recommended
In the event of using a higher dose of the vaccine than recommended, consult a doctor. Detailed information can be found at the end of the leaflet in the "Information intended exclusively for healthcare professionals" section.
Missing a dose of Polyvaccinum forte vaccine
In case of doubt, consult a doctor.
Stopping the use of Polyvaccinum forte vaccine
In case of further doubts about the use of this vaccine, consult a doctor, pharmacist, or nurse.
4. Possible side effects
Like any vaccine, this vaccine can cause side effects, although not everyone will experience them.
Frequency not known (frequency cannot be determined from available data):
- headache
- nausea
- redness, swelling, pain at the injection site
- transient, lasting 6-8 hours fever (up to 38°C)
- malaise, general weakness
- local inflammatory conditions (exacerbation).
These symptoms usually resolve within 24 hours.
Warning:
If side effects such as headache, nausea, and general weakness persist, extend the time between injections and reduce the dose of the vaccine (return to the vaccine concentration containing ten times fewer bacteria and/or reduce the volume of the vaccine dose).
Reporting side effects
If you experience any side effects, including any side effects not listed in this leaflet, tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: 22 49-21-301, fax: 22 49-21-309, e-mail: [email protected]. Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medicine.
5. How to store Polyvaccinum forte vaccine
Store in a refrigerator (2°C - 8°C).
Keep the vaccine out of sight and reach of children.
Do not use the vaccine after the expiry date stated on the carton.
The expiry date refers to the last day of the stated month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
6. Package contents and other information
What Polyvaccinum forte vaccine contains
The active substances of the vaccine are inactivated (killed) bacteria:
Staphylococcus aureus, Staphylococcus epidermidis
500 million cells/1 ml
Escherichia coli, Corynebacterium pseudodiphtheriticum
200 million cells/1 ml
Streptococcus salivarius, Streptococcus pneumoniae,
Streptococcus pyogenes, Klebsiella pneumoniae, Haemophilus
influenzae, Moraxella catarrhalis
100 million cells/1 ml
Other ingredients are: phenol, sodium chloride, disodium phosphate dodecahydrate, sodium dihydrogen phosphate dihydrate, and water for injections.
What Polyvaccinum forte vaccine looks like and what the package contains
The vaccine is a milky suspension with a white tint. During storage, a white sediment forms at the bottom of the ampoule, and above it, a clear supernatant (liquid) forms.
The package contains 5 ampoules of 1 ml each.
Marketing authorization holder and manufacturer
Biomed S.A.
Al. Sosnowa 8
30-224 Kraków
Tel.: +48 12 37 69 200
Fax: +48 12 37 69 205
e-mail: [email protected]
Date of last update of the leaflet:
------------------------------------------------------------------------------------------------------------------------
Information intended exclusively for healthcare professionals:
Administration of Polyvaccinum forte vaccine
Shake before use. After shaking, Polyvaccinum forte vaccine is a milky suspension with a white tint.
Visually inspect the vaccine for any foreign particles and/or changes in appearance. If any changes are observed, do not use the vaccine.
Administer intramuscularly or subcutaneously.
The recommended injection site is the deltoid muscle.
Do not administer intravenously! Make sure the needle is not inserted into a blood vessel.
In the event of using a higher dose of the vaccine than recommended, extend the time between injections and reduce the dose of the vaccine (return to the vaccine concentration containing ten times fewer bacteria and/or reduce the volume of the vaccine dose).
Note: Due to the risk of anaphylactic shock associated with the administration of vaccines, the vaccination room should be equipped with a standard emergency kit.
- Country of registration
- Prescription requiredNo
- Manufacturer
- ImporterInstytut Biotechnologii Surowic i Szczepionek BIOMED S.A.
- This information is for reference only and does not constitute medical advice. Always consult a licensed doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to Polivaccinum forte Niesvoista shhepionka bakteriinaDosage form: Powder, 10 mcg Haemophilus influenzae type b polysaccharide conjugated with 18-30 mcg tetanus toxoid/0.5 ml; 1 dose (0.5 ml)Active substance: haemophilus influenzae B, purified antigen conjugatedManufacturer: Sanofi PasteurPrescription requiredDosage form: Suspension, 1 dose (0.5 ml)Active substance: pertussis, purified antigen, combinations with toxoidsPrescription requiredDosage form: Powder, 2-8x10^6 CFU/mlActive substance: tuberculosis, live attenuatedManufacturer: AJ Vaccines A/SPrescription required
Alternatives to Polivaccinum forte Niesvoista shhepionka bakteriina in other countries
The best alternatives with the same active ingredient and therapeutic effect.
Alternative to Polivaccinum forte Niesvoista shhepionka bakteriina in Ukraina
Online doctors for Polivaccinum forte Niesvoista shhepionka bakteriina
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for Polivaccinum forte Niesvoista shhepionka bakteriina – subject to medical assessment and local rules.
Get updates and exclusive offers
Be the first to know about new services, marketplace updates, and subscriber-only promos.
